Patient Case #2 Continued: Novel Second-Generation Antipsychotics

A panel of experts in psychiatry consider the use of a novel second-generation antipsychotic for the management of treatment resistant depression.

EP: 1.Patient Case #1: 27-Year-Old Woman With Bipolar Disorder

EP: 2.Clinical Significance of Bipolar Disorder

EP: 3.Clinical Impressions From Patient Case #1

EP: 4.Diagnosis of Bipolar Disorder

EP: 5.Treatment Options for Bipolar Disorder

EP: 6.Patient Case #2: 47-Year-Old Man With Treatment Resistant Depression (TRD)

Now Viewing

EP: 7.Patient Case #2 Continued: Novel Second-Generation Antipsychotics

EP: 8.Role of Telemedicine in Bipolar Disorder

Related Videos

Related Content

Advertisement

July 21st 2025

Potential Label Expansion for Igalmi: Pre-Supplemental New Drug Application Meeting Package Submitted

Leah Kuntz

August 4th 2021

Blue Light, Depression, and Bipolar Disorder

Chris Aiken, MD Kellie Newsome, PMH-NP

June 19th 2025

The Overlap in Sleep Problems and Psychiatric Disorders

Ruth Benca, MD, PhD

August 3rd 2021

Four Myths About Lamotrigine

Chris Aiken, MD Kellie Newsome, PMH-NP

May 13th 2025

Diagnosis in Bipolar Disorder: Dealing With Comorbidity

David N. Osser, MD

May 12th 2025

What’s Perfusion Got to Do With It?

Steven R. Devore Best, MD Dan Pavel, MD

Related Content

Advertisement

July 21st 2025

Potential Label Expansion for Igalmi: Pre-Supplemental New Drug Application Meeting Package Submitted

Leah Kuntz

August 4th 2021

Blue Light, Depression, and Bipolar Disorder

Chris Aiken, MD Kellie Newsome, PMH-NP

June 19th 2025

The Overlap in Sleep Problems and Psychiatric Disorders

Ruth Benca, MD, PhD

August 3rd 2021

Four Myths About Lamotrigine

Chris Aiken, MD Kellie Newsome, PMH-NP

May 13th 2025

Diagnosis in Bipolar Disorder: Dealing With Comorbidity

David N. Osser, MD

May 12th 2025

What’s Perfusion Got to Do With It?

Steven R. Devore Best, MD Dan Pavel, MD